FGAM
SVA
Financial Gravity Asset Management’s Sinovac Biotech, Ltd SVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $0 | Buy |
+23
| New | – | ﹤0.01% | 1062 |
|
2024
Q2 | $0 | Sell |
61
-76
| -55% | – | ﹤0.01% | 2645 |
|
2024
Q1 | $0 | Sell |
137
-911
| -87% | – | ﹤0.01% | 2125 |
|
2023
Q4 | $3.2M | Buy |
1,048
+60
| +6% | +$183K | 0.03% | 159 |
|
2023
Q3 | $3.2M | Buy |
+988
| New | +$3.2M | 0.04% | 154 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 1809 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 1786 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 1573 |
|
2022
Q3 | – | Sell |
-144
| Closed | -$796 | – | 899 |
|
2022
Q2 | $796 | Hold |
144
| – | – | 0.02% | 341 |
|
2022
Q1 | $796 | Hold |
144
| – | – | 0.02% | 358 |
|
2021
Q4 | $796 | Buy |
144
+21
| +17% | +$116 | 0.02% | 416 |
|
2021
Q3 | $6K | Hold |
123
| – | – | ﹤0.01% | 924 |
|
2021
Q2 | $6K | Hold |
123
| – | – | ﹤0.01% | 947 |
|
2021
Q1 | $798 | Hold |
123
| – | – | 0.02% | 346 |
|
2020
Q4 | $1K | Buy |
+123
| New | +$1K | ﹤0.01% | 469 |
|
2020
Q2 | – | Sell |
-184
| Closed | -$1.18K | – | 1110 |
|
2020
Q1 | $1.18K | Hold |
184
| – | – | ﹤0.01% | 456 |
|
2019
Q4 | $6K | Buy |
184
+1
| +0.5% | +$33 | ﹤0.01% | 1259 |
|
2019
Q3 | $1K | Hold |
183
| – | – | ﹤0.01% | 1168 |
|
2019
Q2 | $1K | Sell |
183
-2
| -1% | -$11 | ﹤0.01% | 1197 |
|
2019
Q1 | $1K | Buy |
+185
| New | +$1K | ﹤0.01% | 1297 |
|
2018
Q3 | $4K | Buy |
561
+101
| +22% | +$720 | ﹤0.01% | 828 |
|
2018
Q2 | $3K | Buy |
460
+325
| +241% | +$2.12K | ﹤0.01% | 941 |
|
2018
Q1 | $1K | Buy |
+135
| New | +$1K | ﹤0.01% | 1373 |
|